BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3562519)

  • 1. [The biologic availability of acetylsalicylic acid suppositories].
    Süss W; Martin A
    Pharmazie; 1986 Nov; 41(11):817-8. PubMed ID: 3562519
    [No Abstract]   [Full Text] [Related]  

  • 2. The study of the bioavailability of coated acetylsalicylic acid in suppositories after rectal administration.
    Stozek T
    Pol J Pharmacol Pharm; 1975; 27(2):227-33. PubMed ID: 1153355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The bioavailability of combination preparations of acetylsalicylic acid and codeine phosphate].
    Spahn H; Altmayer P; Cattarius-Korb S; Krüger B; Lang E; Mutschler E; Sörgel F
    Arzneimittelforschung; 1985; 35(6):973-6. PubMed ID: 4026924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability and tolerance studies on acetylsalicylic acid suppositories.
    Borg KO; Ekenved G; Elofsson R; Sjögren J; Sölvell L
    Acta Pharm Suec; 1975; 12(5-6):491-8. PubMed ID: 1217502
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the bioavailability of aspirin tablets and suppositories.
    Superstine SY; Superstine E; Penchas S
    Isr J Med Sci; 1978 Feb; 14(2):292-4. PubMed ID: 649361
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioavailability of aspirin after oral and rectal administration in volunteers and patients with fever.
    Dalvi SS; Gupta KC; Pohujani SM; Vaidya AB; Satoskar RS
    J Postgrad Med; 1985 Oct; 31(4):192-5. PubMed ID: 3834082
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioavailability studies on a buffered acetylsalicylic acid preparation.
    Ekenved G; Elofsson R; Sölvell L
    Acta Pharm Suec; 1975; 12(4):323-32. PubMed ID: 1106118
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biopharmaceutics studies of acetylsalicylic acid: use of a pharmacological test for bioavailability study of different acetylsalicylic acid dosage forms (author's transl)].
    Sado PA; Linée P; Le Verge R; Devissaguet JP
    J Pharm Belg; 1977; 32(6):549-60. PubMed ID: 612698
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of dimethyl sulfoxide, dimethylformamide and dimethyl-acetamide on the bioavailability of rectally administered drugs].
    Hadad P; Moran I; Cid E
    Ann Pharm Fr; 1975 May; 33(5):265-71. PubMed ID: 1211789
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacokinetics of acetylsalicylic acid].
    Pütter J
    Med Welt; 1976 Jul; 27(28):1362-5. PubMed ID: 785144
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative studies on the in vitro dissolution and bioavailability of various acetylsalicylic acid preparations].
    Nieder M; Rasper J; Gielsdorf W; Russmann D; Jaeger H
    Arzneimittelforschung; 1983; 33(3):439-45. PubMed ID: 6683520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of meprobamate following its oral and rectal administration as a series of combinations with diphenhydramine, acetylsalicylic acid, codeine and pentaerythritol tetranitrate.
    Gilbert JD; Aylott RI; Sögtrop HH; Draffan GH
    Arzneimittelforschung; 1984; 34(10):1323-7. PubMed ID: 6549136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
    Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectal absorption from aspirin suppositories in children and adults.
    Nowak MM; Brundhofer B; Gibaldi M
    Pediatrics; 1974 Jul; 54(1):23-6. PubMed ID: 4834297
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioavailability of aspirin from commercial suppositories.
    Gibaldi M; Grundhofer B
    J Pharm Sci; 1975 Jun; 64(6):1064-6. PubMed ID: 1133735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative pharmacokinetics and relative bioavailability of the active principles diazepam, acetylsalicylic acid, caffeine, and dihydroergotamine tartrate in a combination product].
    Degen J; Maier-Lenz H
    Arzneimittelforschung; 1982; 32(3):289-93. PubMed ID: 7200787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bioavailability of buffered acetylsalicylic acid].
    Finzi GF; Riolo U; Ghini R
    Arch Sci Med (Torino); 1981; 138(4):467-9. PubMed ID: 7340731
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the pharmacokinetics of tiaprofenic acid and its possible interactions with acetylsalicylic acid and aluminum hydroxide (author's transl)].
    Marećek N; Lücker PW; Penth B; Altmayer P; Wetzelsberger K
    Arzneimittelforschung; 1981; 31(1):116-20. PubMed ID: 6971108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of suppository bases upon the rectal absorption of acetylsalicylic acid.
    CACCHILLO AF; HASSLER WH
    J Am Pharm Assoc Am Pharm Assoc; 1954 Nov; 43(11):683-5. PubMed ID: 13211425
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acetylsalicylic acid suppositories with a lipophilic base. 2. Chemical stability of the active ingredient].
    Karolyi I; Kedvessy G; Regdon G; Regdon E
    Pharmazie; 1976; 31(3):179-80. PubMed ID: 959272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.